Latest filing published 29 Apr 2024 for Lexicon Pharmaceuticals, INC..
Insider track record
No signal scores available.
Robert J. Lefkowitz MD: trading record in brief
Robert J. Lefkowitz MD (board member) discloses dealings in Lexicon Pharmaceuticals, Inc. to SEC (Form 4). Between 27 April 2012 and 28 April 2024, the trades on record add up to 12 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 29 April 2024, the filings show an option exercise in Lexicon Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert J. Lefkowitz MD
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,032 shares0Common StockSEC:0001127602-24-013556:0
- 9,302 shares0Common StockSEC:0001127602-23-016433:0
- 4,024 shares0Common StockSEC:0001127602-22-012829:0
- 10,638 shares0Common StockSEC:0001127602-21-014520:0
- 3,466 shares0Common StockSEC:0001127602-20-014565:0
- 2,564 shares0Common StockSEC:0001127602-18-015446:0
- 1,281 shares0Common StockSEC:0001127602-17-016063:0
- 1,432 shares0Common StockSEC:0001127602-16-050556:0
- 18,691 shares0Common StockSEC:0001127602-15-015093:0
- 12,820 shares0Common StockSEC:0001127602-14-015447:0
- 10,101 shares0Common StockSEC:0001127602-13-016611:0
- 11,764 shares0Common StockSEC:0001127602-12-014805:0
12 of 12 declarations